CAS No: 871038-72-1
Empirical formula: C20H20FKN6O5
Molecular weight: 482.51
Raltegravir is an antiretroviral Active Pharmaceutical Ingredient (API) that inhibits HIV integrase. It is clinically used to treat the HIV infection and decrease infection rates by preventing insertion of HIV-1 DNA into the host genome. Raltegravir is the first-in-class integrase inhibitor.
We offer raltegravir API manufactured using a non-infringing and competitive process with respect to the prior art in terms of raw material consumptions, atom and step economy.
The process was designed, developed and optimized in-house for lean and scalable manufacturing, providing an additional advantage for high-volume products such as Raltegravir.
We also offer advantageous and non-infringing crystalline form options, which enable early access to the European market.